期刊文献+

加强我国药品GLP管理的对策及建议 被引量:2

Strategy and Suggestion on Strengthening Regulation of National Pharmaceuticals GLP
在线阅读 下载PDF
导出
摘要 目的为完善我国药品GLP管理提出对策及建议。方法通过比较国内外药品GLP管理要求,进而分析了我国药品GLP管理存在的问题,提出提升我国药品GLP管理水平的应对策略。结果与结论发现工作者认知水平存在差异,我国GLP与国际GLP法理存在差距等问题。采取加强政府规制,提高从业者责任意识,以及利用信息技术构建GLP平台的对策,以期对提高我国GLP管理水平给予一定指导和帮助。 Objective To perfect the management of our national GLP, and render measures and advice. Methods Based on the comparison of medicine GLP management requirements at home and abroad, some existing problems at home were analyzed, and the coping strategies were put forward to promote Chinese GLP management. Results and Conclusion There exist differences in operating staff quality and idea of law for domestic and foreign GLP management. Strengthening government regulation, enhancing staff's sense of responsibility as well as establishing a GLP information platform are the advice put forward to promote Chinese GLP management.
出处 《中国药事》 CAS 2014年第4期365-367,共3页 Chinese Pharmaceutical Affairs
关键词 药品GLP 管理 对策 建议 medicine GLP management strategy suggestion
  • 相关文献

参考文献4

二级参考文献21

共引文献19

同被引文献16

  • 1颜耀东,黄晓洁,王楠.药品质量标准与药品质量评价相关性的探讨[J].中国药房,2007,18(34):2650-2652. 被引量:17
  • 2常福厚,白图雅,吕晓丽.药物毒理学研究的现状及与创新药物研究的关系[J].中国药理学与毒理学杂志,2013,27(3):488-489.
  • 3魏金锋,王风华,李海艳,等.GLP实验室质量管理体系的建立[J].中国药理学与毒理学杂志,2013,27(3):505.
  • 4Matthew OW, Judith AS, Stuart MM, et al. Post-market drug evaluation research training capacity in Canada: an environ- mental scan of Canadian educational institutions[J]. J Popul Ther Clin Pharmacol, 2014, 21(3):370-378.
  • 5]Varallo FR, Guimaraes Sde O, Abjaude SA, et al. Causes for the underreporting of adverse drug events by health profes- sionals: a systematic review[J]. Rev Esc Enferm USP, 2014, 48(4):739-747.
  • 6LaBute MX, Zhang X, Lenderman J, et al. Adverse drug re- action prediction using scores produced by large-scale drug- protein target docking on high-performance computing ma- chines[J]. PLoS One, 2014, 9(9):e106298. doi: 10.1371/jour- nal.pone.0106298, eCollection 2014.
  • 7Kuang Q, Wang M, Li R, et al. A systematic investigation of computation models for predicting adverse drug reactions (ADRs) [J]. PLoS One, 2014, 9(9):el05889. doi: 10.1371/ journal.pone.0105889, eCollection 2014.
  • 8杨志敏,杜晓曦.中、美药品注册管理法规体系的比较研究[J].食品与药品,2009,11(1):1-4. 被引量:11
  • 9Laura Luo Michael Shao Lina Svedlund.国际新药临床前毒理学研究要求及对中国新药开发的启示[J].中国新药杂志,2009,18(6):469-472. 被引量:5
  • 10王宏涛.药物安全性评价与GLP建设[J].中南药学,2010,8(10):775-777. 被引量:5

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部